| 2018 | | 469: Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis | 최용원, 박태준,안미선, 이현우,정성현, 강석윤,박준성, 최진혁 |
| 2013 | | 5-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection. | 안미선, 강석윤,이현우, 정성현,박준성, 이광재,조용관, 한상욱,이순영, 최진혁 |
| 2009 | | A case of bladder rhabdomyosarcoma in an adult | 최용원, 김세중,주희재, 강석윤 |
| 2010 | | A case of donor-derived granulocytic sarcoma after allogeneic hematopoietic stem cell transplantation | 정성현, 한재호,정선용, 강석윤,이현우, 최진혁,박준성 |
| 2009 | | A case of head and neck rhabdomyosarcoma with pancreatic metastasis | 최용원, 안미선,한재호, 강석윤 |
| 2009 | | A Case Report of Helicobacter Pylori Negative Gastric MALT Lymphoma with Monoclonal Gammopathy | 정성현, 이현우,강석윤, 최진혁,한재호, 김장희,김명욱, 유병무,박준성 |
| 2016 | | A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting | 강석윤 |
| 2016 | | A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806) | 강석윤, 최진혁 |
| 2011 | | A novel algorithm for detection of adverse drug reaction signals using a hospital electronic medical record database | 이기영, 강석윤,박인휘, 감혜진,박래웅 |
| 2013 | | A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer. | 강석윤 |
| 2017 | | A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer | 강석윤 |
| 2019 | | Abrogation of B-Raf(V600E) induced senescence by FoxM1 expression | 최용원, 김장희,강석윤, 박태준 |
| 2012 | | Acquired hemophilia successfully treated with activated prothrombin complex concentrate and immunosuppressant combination: a case report | 안미선, 정성현,박준성, 강석윤,최진혁, 이현우 |
| 2017 | | Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer | 노오규, 김지훈,전미선, 오영택,강석윤, 이현우,박래웅, 윤덕용 |
| 2007 | | Aging Effects on Dendritic Cells after Total Body Irradiation in Mice | 정성현, 이현우,강석윤, 최진혁,김효철, 박준성 |
| 2018 | | Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study | 이현우, 강석윤 |
| 2011 | | Bax predicts outcome in gastric cancer patients treated with 5-fluorouracil, leucovorin, and oxaliplatin palliative chemotherapy. | 정성현, 한재호,김장희, 안미선,이현우, 강석윤,박준성, 최진혁,이광재, 신승수 |
| 2016 | | Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer | 강석윤 |
| 2009 | | Clinical Significance of Co-expression of Aberrant Antigens in Acute Leukemia | 정성현, 이현우,안미선, 강석윤,최진혁, 김효철,조성란, 박준성 |
| 2014 | | Clinical significance of cryptic chromosomal translocations detected by multiplex RT-PCR in patients with acute leukemia. | 박준성, 최진혁,강석윤, 이현우,안미선, 조성란,정성현 |
| 2014 | | Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial. | 강석윤 |
| 2008 | | Comparison of multiplex reverse transcription polymerase chain reaction and conventional cytogenetics as a diagnostic strategy for acute leukemia. | 박준성, 정성현,이현우, 강석윤,최진혁, 김효철,박준은, 임영애,김현주, 조성란 |
| 2013 | | Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer. | 전자영, 강석윤,정용식, 김지영,안미선, 강두경,김태희, 임현이,안영실, 박래웅,김구상 |
| 2016 | | Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic Treatments | 김상원, 전미선,한세환, 정용식,최진혁, 강석윤 |
| 2006 | | Concurrent chemoradiotherapy in patients with nasopharyngeal cancer: prognostic significance of low expression of bax. | 강석윤, 오영택,한재호, 최진혁,이현우, 장준호,박준성, 김효철,강승희, 전미선,김철호, 주희재 |
| 2009 | | Concurrent Chemoradiotherapy with Weekly Paclitaxel for Locally Advanced Non-small Cell Lung Cancer | 정성현, 이현우,강석윤, 안미선,오영택, 최진혁,신승수, 박광주 |
| 2009 | | Difference in Viability of CD34+ Cells in Cryopreserved Cord Blood According to Evaluation Methods | 박준성, 최진혁,강석윤, 이현우,김효철, 정성현 |
| 2012 | | Differential diagnosis in idiopathic granulomatous mastitis and tuberculous mastitis | 임현이, 김태희,강두경, 오기근,강석윤, 안영실,전미선, 박래웅,정용식, 김구상 |
| 2015 | | Does the timing of adjuvant chemotherapy for gastric cancer influence patient outcome? | 강석윤, 안미선,최용원, 이현우,정성현, 박준성,조용관, 한상욱,신승수, 한재호,최진혁 |
| 2018 | | Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy | 강석윤 |
| 2018 | | EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non-Small Cell Lung Cancer Patients | 최용원, 이현우,정성현, 강석윤,박준성, 최진혁,고영화, 한재호,신승수 |
| 2007 | | Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells. | 이현우, 강석윤,박준성, 최진혁,김효철 |
| 2010 | | Expression of Bcl-2 predicts outcome in locally advanced non-small cell lung cancer patients treated with cisplatin-based concurrent chemoradiotherapy. | 정성현, 한재호,김장희, 이현우,강석윤, 최진혁,오영택, 전미선,박광주, 황성철,신승수 |
| 2009 | | Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy. | 이현우, 한재호,김장희, 정재호,정성현, 강석윤,최진혁, 오영택,박광주, 황성철,신승수 |
| 2008 | | Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer. | 이현우, 한재호,김장희, 정성현,강석윤, 최진혁,오영택, 박광주,황성철, 신승수 |
| 2001 | | Factors Affecting Mobilization and Engraftment in High Dose Chemotherapy with Fixed Dose of Glycosylated rHuG-CSF(Lenograstim) | 강석윤 |
| 2017 | | Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results | 강석윤 |
| 2013 | | Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression. | 김장희, 임현이,강석윤, 정용식,박태준 |
| 2013 | | Granulocytic sarcoma in breast after bone marrow transplantation. | 정성현, 강석윤,김태희, 강두경,임현이, 정용식,김구상 |
| 2012 | | Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection | 강석윤, 한재호,안미선, 이현우,정성현, 박준성,조용관, 한상욱,김영배, 김장희,신승수, 최진혁 |
| 2016 | | High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy | 최용원, 안미선,최진혁, 이현우,강석윤, 정성현,박준성, 한재호,김장희, 신승수 |
| 2010 | | High expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with nasopharyngeal cancer. | 이현우, 한재호,최진혁, 강석윤,정성현, 안미선,오영택, 김장희,김철호, 신승수 |
| 2015 | | Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer? | 최용원, 안미선,이현우, 정성현,강석윤, 박준성,최진혁, 이순영 |
| 2007 | | Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. | 강석윤, 한재호,이광재, 최진혁,이현우, 박준성,김효철, 강승희,오영택, 전미선,김장희, 신승수 |
| 2008 | | Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology. | 정성현, 이현우,한재호, 강석윤,최진혁, 최호,오영택, 박광주,황성철, 신승수,김장희 |
| 2012 | | Magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity | 김태희, 강두경,임현이, 정용식,김구상, 강석윤 |
| 2015 | | Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer. | 강석윤 |
| 2017 | | Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients | 강석윤 |
| 2013 | | Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905). | 강석윤 |
| 2015 | | Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation. | 최용원, 정성현,안미선, 이현우,강석윤, 최진혁,박준성 |
| 2009 | | Outcome of Locally Advanced Esophageal Cancer Treated with Concurrent Chemo-radiotherapy | 강승희, 오영택,전미선, 최진혁,강석윤 |
| 2014 | | Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP. | 최용원, 정성현,안미선, 이현우,강석윤, 최진혁,박준성 |
| 2019 | | Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY) | 강석윤 |
| 2013 | | Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02. | 강석윤 |
| 2018 | | Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in gastric cancer patients who underwent palliative chemotherapy | 강석윤, 최용원,안미선, 이현우,최진혁 |
| 2017 | | Prognostic utility of FDG PET/CT and bone scintigraphy in breast cancer patients with bone-only metastasis | 윤준기, 이수진,강석윤, 임현이,안영실 |
| 2016 | | Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study | 강석윤 |
| 2015 | | Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02). | 강석윤 |
| 2012 | | Risk Reducing Surgery in Carriers with Double Heterozygosity for BRCA1 and BRCA2 Mutations | 홍우성, 김구상,정용식, 강석윤,강두경, 김태희,임현이, 전미선,박명철, 장석준 |
| 2019 | | S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial | 강석윤 |
